Renal replacement therapy in patients with diabetes and end-stage renal disease.
about
Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine FamilyFree Fatty acids and their metabolism affect function and survival of podocytesClinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin.Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients.End stage renal disease.Clinical outcomes and quality of life in hemodialysis diabetic patients versus non-diabetics.End-stage renal diseasePretransplantation erythropoiesis-stimulating agent hyporesponsiveness is associated with increased kidney allograft failure and mortality.Regulation of podocyte survival and endoplasmic reticulum stress by fatty acidsOral supplementation with cholecalciferol 800 IU ameliorates albuminuria in Chinese type 2 diabetic patients with nephropathySurvival of living-related kidney graft recipients in the era of modern immunosuppressive treatment.Peritoneal dialysis in diabetics: there is room for more.Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathyDiabetes: changing the fate of diabetics in the dialysis unit.Diabetes and the urologist: a growing problem.New hepatitis B vaccine formulated with an improved adjuvant system.Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes: Results From a Nationwide Prospective Cohort in Korea.The diabetic foot in end stage renal disease.Access to renal transplantation in the diabetic population-effect of comorbidities and body mass index.Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signalingSusceptibility of podocytes to palmitic acid is regulated by stearoyl-CoA desaturases 1 and 2.Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2.Superior outcomes of kidney transplantation compared with dialysis: An optimal matched analysis of a national population-based cohort study between 2005 and 2008 in Korea.Outcome of renal transplantation in patients with diabetic nephropathy -- a single-center experience.Cardiovascular risk in diabetic end-stage renal disease patients.Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country.Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence.Differential effects of Smad3 targeting in a murine model of chronic kidney diseaseFetuin-A aggravates lipotoxicity in podocytes via interleukin-1 signaling.(+)-Catechin ameliorates diabetic nephropathy by trapping methylglyoxal in type 2 diabetic mice.Calcium Uptake via Mitochondrial Uniporter Contributes to Palmitic Acid-Induced Apoptosis in Mouse Podocytes.Increases in peritoneal small solute transport in the first month of peritoneal dialysis predict technique survival.Spatial Analysis of Case-Mix and Dialysis Modality Associations.Evidence-based choice of dialysis technique in diabetics with end-stage kidney disease: half a loaf is better than no bread.Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy.Parameters of glycemic control in type 2 diabetic patients on hemodialysis or peritoneal dialysis: implications for clinical practice.Cardiovascular complications in diabetic patients undergoing regular hemodialysis: a 5-year observational study.[Increase in prevalence of diabetes mellitus as a cause of dialytic end-stage renal disease: analysis of 20 years in the west region of Paraná].The effects of spironolactone on nephron function in patients with diabetic nephropathy.Processing advanced glycation end product-modified albumin by the renal proximal tubule and the early pathogenesis of diabetic nephropathy.
P2860
Q26801150-BE611EA6-2EE5-4EA0-AA7E-A98CB15C846FQ27001123-948DC1D7-2853-4AAC-8D62-30A119EE0DA8Q30419381-2EF014AC-9D5D-4DAD-88B5-5BC4A6918789Q30427039-C59677A5-D7FC-43DA-8A94-34C8B5762CBCQ33446829-0767CB4F-8196-47DC-8185-7CEFD19243F3Q33638697-C5283819-011D-4EE9-9424-972AB794ED08Q33850437-3603D802-E610-4BAB-B70F-20A7130E4AF7Q33871590-E952F191-294B-4692-8D2C-B9C93851DB32Q34211573-0F0935BC-8053-445F-8196-E1BF13C9940AQ34500399-F6CE2D95-9D5E-4F32-9175-321261D3D1C5Q35059593-3D787CFB-C0FC-4105-A19C-D1E8D7B28E95Q35371053-F6DBF9C6-2CA1-4CBA-9A3F-199ACA40F201Q36117573-5A07ECA0-47FA-4AD6-88E2-AD0A4D3F3528Q36684720-43A37DE8-6D7D-45B8-93B5-1A666FB4B4A3Q36687040-9060E785-1CCE-437D-99BA-21E3A1FC4633Q36780117-E87CA89C-0B18-4E84-A7E3-C9E77490C950Q36822903-C51E0428-48DE-4F6B-A3FB-4A249958F7A2Q36892436-F2C9E925-3B5B-46D7-8246-49F0135F92DBQ37129051-5F3AEBA1-50E2-4126-9FA3-A58A1C5C1646Q37129456-8F2460F6-C1B8-47E4-8834-718220B00274Q37149077-AA3E6E3A-AEBD-4B12-AEC0-7107BF2542F2Q37575477-E04372F1-70CB-46BA-A709-A8415BAD949CQ37726660-ED157FA0-1689-4C32-A19B-4AC8AC3D653BQ37812286-84B15267-35EE-49E8-B209-F091DF117408Q37877789-148BFA93-DA53-4C0D-8171-567920FF7C5BQ37909083-3F944D28-64EE-4A67-9DEB-0636308CB99FQ38253492-BEAC1569-0104-4292-A6C1-0DACDE15C6A7Q38568865-440813C2-0311-416A-8D52-6539AF8D064FQ38758052-BB0BCE07-97A6-4EBD-A55A-CFD4DC465C7EQ38954339-39454AC8-FD79-4F67-ADD9-A1E17E7F583DQ38970182-36A19689-F65E-47AD-8BC8-B112891C88ECQ39129691-4E70EB25-D50A-4C30-B76B-B6CA3CADAA69Q41207233-C9FAC270-09B2-463F-8126-0BB5B5ED1872Q41670704-F955FF95-74FE-4962-8861-B51BC0E0E2F3Q42167256-B8AE954D-204C-47F3-B191-9B9C269CD9D1Q44222296-959D1FAB-7445-4ADB-8F38-182E333D3ABDQ44491090-D3F47FC0-A902-4395-B0E9-CEF1B373E42EQ44690129-301D6D67-418F-48C1-9ADA-0489948754DFQ46240721-CC3CD638-561E-4D1F-9604-C75212C96C33Q46613199-26BDAAE4-B73E-4A26-9E3F-972804C3E428
P2860
Renal replacement therapy in patients with diabetes and end-stage renal disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Renal replacement therapy in patients with diabetes and end-stage renal disease.
@ast
Renal replacement therapy in patients with diabetes and end-stage renal disease.
@en
type
label
Renal replacement therapy in patients with diabetes and end-stage renal disease.
@ast
Renal replacement therapy in patients with diabetes and end-stage renal disease.
@en
prefLabel
Renal replacement therapy in patients with diabetes and end-stage renal disease.
@ast
Renal replacement therapy in patients with diabetes and end-stage renal disease.
@en
P2093
P1476
Renal replacement therapy in patients with diabetes and end-stage renal disease.
@en
P2093
Francesco Locatelli
Lucia Del Vecchio
Pietro Pozzoni
P356
10.1097/01.ASN.0000093239.32602.04
P478
15 Suppl 1
P577
2004-01-01T00:00:00Z